1. Home
  2. BMR vs SCYX Comparison

BMR vs SCYX Comparison

Compare BMR & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMR
  • SCYX
  • Stock Information
  • Founded
  • BMR 2009
  • SCYX 1999
  • Country
  • BMR Israel
  • SCYX United States
  • Employees
  • BMR N/A
  • SCYX N/A
  • Industry
  • BMR Computer Software: Prepackaged Software
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMR Technology
  • SCYX Health Care
  • Exchange
  • BMR Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • BMR 41.9M
  • SCYX 34.9M
  • IPO Year
  • BMR 2023
  • SCYX 2014
  • Fundamental
  • Price
  • BMR $2.97
  • SCYX $1.00
  • Analyst Decision
  • BMR
  • SCYX
  • Analyst Count
  • BMR 0
  • SCYX 0
  • Target Price
  • BMR N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • BMR 875.5K
  • SCYX 223.4K
  • Earning Date
  • BMR 08-13-2025
  • SCYX 11-05-2025
  • Dividend Yield
  • BMR N/A
  • SCYX N/A
  • EPS Growth
  • BMR N/A
  • SCYX N/A
  • EPS
  • BMR N/A
  • SCYX N/A
  • Revenue
  • BMR $3,131,000.00
  • SCYX $3,257,000.00
  • Revenue This Year
  • BMR $21.21
  • SCYX $422.61
  • Revenue Next Year
  • BMR N/A
  • SCYX $240.56
  • P/E Ratio
  • BMR N/A
  • SCYX N/A
  • Revenue Growth
  • BMR 5.96
  • SCYX N/A
  • 52 Week Low
  • BMR $1.86
  • SCYX $0.66
  • 52 Week High
  • BMR $6.59
  • SCYX $1.65
  • Technical
  • Relative Strength Index (RSI)
  • BMR 52.21
  • SCYX 59.36
  • Support Level
  • BMR $2.78
  • SCYX $0.98
  • Resistance Level
  • BMR $2.98
  • SCYX $1.31
  • Average True Range (ATR)
  • BMR 0.15
  • SCYX 0.08
  • MACD
  • BMR 0.02
  • SCYX 0.01
  • Stochastic Oscillator
  • BMR 87.82
  • SCYX 42.00

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: